The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Change in risk of Alzheimer disease over time
Open accessAbstract
OBJECTIVE: To assess whether the risk of incidence of Alzheimer disease (AD) varies over time. The increase in numbers of people at the oldest ages in the population will bring an increase in the number of people with AD. Projections of the size of the increase assume the risk of AD is constant. METHODS: All persons age 65 or older in a biracial, geographically defined area were invited to participate in a home interview every 3 years. From the approximately 10,000 participants, stratified random samples were selected for detailed clinical evaluation. At each cycle, individuals determined free of AD in a previous cycle, either by examination or by high score on cognitive function tests, were sampled in the subsequent cycle for evaluation for incident AD. The evaluations for disease were structured and uniform across time. These analyses include 1,695 subjects evaluated for incident disease from 1997 through 2008. RESULTS: AD developed in 360 participants. Change over time in risk of incident disease was assessed in logistic regression analyses including evaluation date and controlling for age, gender, education, race, interval from disease-free designation to evaluation for incident disease, and sample design. The time variable (in years) was not significant (odds ratio = 0.970, 95% confidence interval = 0.902 to 1.044). CONCLUSIONS: The null relation of evaluation date to disease incidence suggests no recent change in risk of AD over time, and supports this assumption for projections of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The greatest risk factors for late-onset Alzheimer's are older age, 62,63 genetics 64,65 -especially the e4 form of the apolipoprotein E (APOE) gene -and having a family history of Alzheimer's.[66][67][68][69]”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [62]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The main risk factor for SAD is age. Indeed, increased life expectancy is correlated with a higher probability of developing neurodegenerative diseases, including AD [89,90].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [89]
The cited source says what the claim attributes to it.
In the citing paper
“The greatest risk factors for Alzheimer's dementia are older age, 70 , 71 genetics — especially the e4 form of the apolipoprotein E (APOE) gene 72 , 73 — and having a family history of Alzheimer's dementia.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,802
Participation in Cognitively Stimulating Activities and Risk of Incident Alzheimer Disease
Wilson, R. S. (2002) · JAMA · doi:10.1001/jama.287.6.742 · Cited by 1,352
Self-citationTang, M.-X. (1998) · JAMA · doi:10.1001/jama.279.10.751 · Cited by 771
Social resources and cognitive decline in a population of older African Americans and whites
Barnes, L. L., Mendes de Leon, C. F., Wilson, R. S., Bienias, J. L., & Evans, D. A. (2004) · Neurology · doi:10.1212/01.wnl.0000147473.04043.b3 · Cited by 572
Self-citationAnnual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 Through 2050
Hebert, L. E., Beckett, L. A., Scherr, P. A., & Evans, D. A. (2001) · Alzheimer Disease and Associated Disorders · doi:10.1097/00002093-200110000-00002 · Cited by 467
Self-citationAge-Specific Incidence of Alzheimer's Disease in a Community Population
Hebert, L. E. (1995) · JAMA · doi:10.1001/jama.1995.03520410048025 · Cited by 462
Self-citationThe Aging, Demographics, and Memory Study: Study Design and Methods
Langa, K. M., Plassman, B. L., Wallace, R. B., Herzog, A. R., Heeringa, S. G., Ofstedal, M. B., Burke, J. R., Fisher, G. G., Fultz, N. H., Hurd, M. D., et al. (2005) · Neuroepidemiology · doi:10.1159/000087448 · Cited by 415
Evans, D. A., Bennett, D. A., Wilson, R. S., Bienias, J. L., Morris, M. C., Scherr, P. A., Hebert, L. E., Aggarwal, N., Beckett, L. A., Joglekar, R., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.185 · Cited by 370
Self-citationDesign of the Chicago Health and Aging Project (CHAP)
Bienias, J. L., Beckett, L. A., Bennett, D. A., Wilson, R. S., & Evans, D. A. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5501 · Cited by 249
Self-citation
Research works printed but not linked: 4
- Bienias JL Kott PS Beck TL Evans DA. Incorporating multiple observations into logistic regression models of incident disease. In: Proceedings of the Annual Meeting of the American Statistical Association Section on Survey Research Methods (CD-ROM: 2767– 2774 ). Alexandria VA: American Statistical Association; 2005.
- Bienias JL Kott PS Evans DA. Applying the delete-a-group jackknife variance estimator to analyses of data from a complex longitudinal survey. In: Proceedings of the Annual Meeting of the American Statistical Association Section on Survey Research Methods (CD-ROM: 539– 544 ). Alexandria VA: American Statistical Association; 2003.
- Little RJA Rubin DB. Statistical Analysis with Missing Data. New York: Wiley; 1987.
- Wolter KM. Introduction to Variance Estimation. New York: Springer-Verlag; 1985.
Cited by
Sorted by citations
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
2022 Alzheimer's disease facts and figures
Anonymous (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12638 · Cited by 2,469
2021 Alzheimer's disease facts and figures
Anonymous (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12328 · Cited by 2,339
2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
Baumgart, M., Snyder, H. M., Carrillo, M. C., Fazio, S., Kim, H., & Johns, H. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.016 · Cited by 1,660
2015 Alzheimer's disease facts and figures
Alzheimer's Association (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.02.003 · Cited by 1,673
2017 Alzheimer's disease facts and figures
(, T. D. B. T. A.-R. C. C. A. S. O. A. C. B. S., different, ). J. A. I. A., destroyed, S. A. T. A. S. T. M. E. T. M. C. I. S. I. A. G. W. A. T. R. N. I. T. O. B. T. F. N. T. B. D. A. D. A. U. I. B. R. I. I. F. N. M. A. N. I. O. P. O. T. B. A. D. A., difficulties, I. E. O., agitation, I. N. S. S. A., & delusions., S. A. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.02.001 · Cited by 1,357
Incidence of dementia over three decades in the Framingham heart study
Satizabal, C. L., Beiser, A. S., Chouraki, V., Chêne, G., Dufouil, C., & Seshadri, S. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504327 · Cited by 1,051
2014 Alzheimer's disease facts and figures
Alzheimer's Association (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.02.001 · Cited by 1,064
The changing prevalence and incidence of dementia over time - current evidence
Wu, Y.-T., Beiser, A. S., Breteler, M. M. B., Fratiglioni, L., Helmer, C., Hendrie, H. C., Honda, H., Ikram, M. A., Langa, K. M., Lobo, A., et al. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.63 · Cited by 775
Mortality and Morbidity Trends: Is There Compression of Morbidity?
Crimmins, E. M., & Beltran-Sanchez, H. (2011) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/gbq088 · Cited by 694
Alzheimer's Disease: Treatment Strategies and Their Limitations.
Passeri, E., Elkhoury, K., Morsink, M., Broersen, K., Linder, M., Tamayol, A., Malaplate, C., Yen, F. T., & Arab-Tehrany, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213954 · Cited by 689
“Indeed, increased life expectancy is correlated with a higher probability of developing neurodegenerative diseases, including AD [89,90].”
BackgroundRocca, W. A., Petersen, R. C., Knopman, D. S., Hebert, L. E., Evans, D. A., Hall, K. S., Gao, S., Unverzagt, F. W., Langa, K. M., Larson, E. B., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.11.002 · Cited by 498
Self-citation2025 Alzheimer's disease facts and figures
(2025) · Alzheimer s & Dementia · doi:10.1002/alz.70235 · Cited by 642
Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study
Schrijvers, E. M. C., Verhaaren, B. F. J., Koudstaal, P. J., Hofman, A., Ikram, M. A., & Breteler, M. M. B. (2012) · Neurology · doi:10.1212/wnl.0b013e3182553be6 · Cited by 408
Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden
Qiu, C., Strauss, E. I. V., Bäckman, L., Winblad, B. G., & Fratiglioni, L. (2013) · Neurology · doi:10.1212/wnl.0b013e318292a2f9 · Cited by 322
Guure, C. B., Ibrahim, N. A., Adam, M. B., & Said, S. M. (2017) · BioMed Research International · doi:10.1155/2017/9016924 · Cited by 298
Resveratrol for Alzheimer's disease
Sawda, C. N., Moussa, C., & Turner, R. S. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13431 · Cited by 287
Rajan, K. B., Weuve, J., Barnes, L. L., Wilson, R. S., & Evans, D. A. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.216 · Cited by 245
Self-citationSteenland, K., Goldstein, F. C., Levey, A. I., & Wharton, W. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150778 · Cited by 226
Trends in dementia prevalence, incidence, and survival rate in a Japanese community
Ohara, T., Hata, J., Yoshida, D., Mukai, N., Nagata, M., Iwaki, T., Kitazono, T., Kanba, S., Kiyohara, Y., & Ninomiya, T. (2017) · Neurology · doi:10.1212/wnl.0000000000003932 · Cited by 214
Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer's Disease
James, B. D., & Bennett, D. A. (2019) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-040218-043758 · Cited by 213
Self-citationThe involvement of NLRP3 inflammasome in the treatment of Alzheimer’s disease
Feng, Y.-S., Tan, Z., Wu, L., Dong, F., & Zhang, F. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101192 · Cited by 186
Vascular Risk Factors and Dementia: 40-Year Follow-Up of a Population-Based Cohort
Rönnemaa, E., Zethelius, B., Lannfelt, L., & Kilander, L. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000330020 · Cited by 171
Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine
Eid, A., Mhatre, I., & Richardson, J. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.005 · Cited by 164
Yan, S., Fu, W., Wang, C., Mao, J., Liu, B., Zou, L., & Lv, C. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0799-5 · Cited by 162
Cognitive and social lifestyle: links with neuropathology and cognition in late life
Bennett, D. A., Arnold, S. E., Valenzuela, M., Brayne, C., & Schneider, J. A. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1226-2 · Cited by 148
Self-citationA critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease
Reddy, P. H., Tonk, S., Kumar, S., Vijayan, M., Kandimalla, R., Kuruva, C. S., & Reddy, A. P. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.067 · Cited by 143
Mukadam, N., Wolters, F. J., Walsh, S., Wallace, L., Brayne, C., Matthews, F. E., Sacuiu, S., Skoog, I., Seshadri, S., Beiser, A., et al. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00120-8 · Cited by 136
Chen, Y., Tysinger, B., Crimmins, E., & Zissimopoulos, J. M. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.04.003 · Cited by 129
Aging without Dementia is Achievable: Current Evidence from Epidemiological Research
Qiu, C., & Fratiglioni, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171037 · Cited by 140
Trends in dementia incidence: Evolution over a 10‐year period in France
Grasset, L., Brayne, C., Joly, P., Jacqmin‐Gadda, H., Pérès, K., Foubert‐Samier, A., Dartigues, J., & Helmer, C. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.11.001 · Cited by 118
Secular Trends in Dementia Prevalence and Incidence Worldwide: A Systematic Review
Stephan, B. C. M., Birdi, R., Tang, E. Y. H., Cosco, T. D., Donini, L. M., Licher, S., Ikram, M. A., Siervo, M., & Robinson, L. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180375 · Cited by 109
Incidence of Dementia and Alzheimer Disease Over Time: A Meta‐Analysis
Gao, S., Burney, H. N., Callahan, C. M., Purnell, C. E., & Hendrie, H. C. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16027 · Cited by 104
Gleason, C. E., Zuelsdorff, M., Gooding, D. C., Kind, A. J. H., Johnson, A. L., James, T. T., Lambrou, N. H., Wyman, M. F., Ketchum, F. B., Gee, A., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12511 · Cited by 104
Trends in Dementia Incidence in a Birth Cohort Analysis of the Einstein Aging Study
Derby, C. A., Katz, M. J., Lipton, R. B., & Hall, C. B. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.1964 · Cited by 98
Gleason, C. E., Norton, D., Zuelsdorff, M. L., Benton, S. F., Wyman, M. F., Nystrom, N. C., Lambrou, N. H., Salazar, H., Koscik, R. L., Jonaitis, E. M., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.07.015 · Cited by 98
MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease
Reddy, P. H., Williams, J. M., Smith, F., Bhatti, J. S., Kumar, S., Vijayan, M., Kandimalla, R. J. L., Kuruva, C. S., Wang, R., Mańczak, M., et al. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.009 · Cited by 89
Dietary pattern in relation to the risk of Alzheimer’s disease: a systematic review
Samadi, M., Moradi, S., Moradinazar, M., Mostafai, R., & Pasdar, Y. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03976-3 · Cited by 89
Kapila, A. K., Watts, H. R., Wang, T., & Ma, D. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132258 · Cited by 88
ECM in brain aging and dementia
Morawski, M., Filippov, M., Tzinia, A., Tsilibary, E., & Vargova, L. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63486-3.00010-4 · Cited by 84
Skoog, I. G., Börjesson‐Hanson, A., Kern, S., Johansson, L. H., Falk, H., Sigström, R., & Östling, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-05022-8 · Cited by 90
Health-economic burden of dementia in South Korea
Shon, C., & Yoon, H. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02526-x · Cited by 74
Dementia incidence declined in African‐Americans but not in Yoruba
Gao, S., Ogunniyi, A. O., Hall, K. S., Baiyewu, O., Unverzagt, F. W., Lane, K. A., Murrell, J. R., Gureje, O., Hake, A. M., & Hendrie, H. C. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.06.1894 · Cited by 75
Physical and Mental Activity, Disease Susceptibility, and Risk of Dementia
Zhu, J., Ge, F., Zeng, Y., Qu, Y., Chen, W., Yang, H., Yang, L., Fang, F., & Song, H. (2022) · Neurology · doi:10.1212/wnl.0000000000200701 · Cited by 77
d’Abramo, C., D'adamio, L., & Giliberto, L. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030116 · Cited by 71
Aging exacerbates impairments of cerebral blood flow autoregulation and cognition in diabetic rats
Wang, S., Lv, W., Zhang, H., Liu, Y., Li, L., Jefferson, J. R., Guo, Y., Li, M., Gao, W., Fang, X., et al. (2020) · GeroScience · doi:10.1007/s11357-020-00233-w · Cited by 63
Logan, R. A., Williams, B. G., da Silva, M. F., Indani, A., Schcolnicov, N., Ganguly, A., & Miller, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.720226 · Cited by 69
Liu, C., Li, C., Sun, Y., & Hu, S. C. (2019) · BioMed Research International · doi:10.1155/2019/5378540 · Cited by 65
Dementia care frameworks and assistive technologies for their implementation: a review
Koumakis, L., Chatzaki, C., Kazantzaki, E., Maniadi, E., & Tsiknakis, M. (2019) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2019.2892614 · Cited by 64
Identification of molecular correlations of RBM8A with autophagy in Alzheimer's disease
Zou, D., Li, R., Huang, X., Chen, G., Liu, Y., Meng, Y., Wang, Y., Wu, Y., & Mao, Y. (2019) · Aging · doi:10.18632/aging.102571 · Cited by 62
IoT-Based Healthcare Support System for Alzheimer’s Patients
Oskouei, R. J., MousaviLou, Z., Bakhtiari, Z., & Jalbani, K. B. (2020) · Wireless Communications and Mobile Computing · doi:10.1155/2020/8822598 · Cited by 65
Freedman, V. A., Kasper, J. D., Spillman, B. C., & Plassman (2018) · The Journals of Gerontology: Series B · doi:10.1093/geronb/gbx144 · Cited by 60
Belonwu, S., Li, Y., Bunis, D. G., Rao, A. A., Solsberg, C. W., Tang, A., Fragiadakis, G. K., Dubal, D. B., Oskotsky, T., & Sirota, M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02591-8 · Cited by 55
Evans, D. A., Grodstein, F., Loewenstein, D., Kaye, J. A., & Weıntraub, S. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.11.008 · Cited by 55
Self-citationSecular Trends in the Incidence of Dementia in a Multi-Ethnic Community
Noble, J. M., Schupf, N., Manly, J. J., Andrews, H., Tang, M., & Mayeux, R. P. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170300 · Cited by 53
Blood-Based Biomarkers of Neuroinflammation in Alzheimer’s Disease: A Central Role for Periphery?
Angiulli, F., Conti, E., Zoia, C., Re, F. D., Appollonio, I. M., Ferrarese, C., & Tremolizzo, L. (2021) · Diagnostics · doi:10.3390/diagnostics11091525 · Cited by 55
Racial/Ethnic Disparities in Alzheimer’s Disease Risk: Role of Exposure to Ambient Fine Particles
Younan, D., Wang, X., Gruenewald, T. L., Gatz, M., Serre, M. L., Vizuete, W., Braskie, M. N., Woods, N. F., He, K., García, L., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab231 · Cited by 51
Renke, M. B., Marcinkowska, A. B., Kujach, S., & Winklewski, P. J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.803332 · Cited by 50
Alzheimer’s Disease in Social Media: Content Analysis of YouTube Videos
Tang, W., Olscamp, K., Choi, S. K., & Friedman, D. B. (2017) · Interactive Journal of Medical Research · doi:10.2196/ijmr.8612 · Cited by 48
Lathuilière, A., Mach, N., & Schneider, B. L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160510578 · Cited by 48
Disclosure of amyloid imaging results to research participants: Has the time come?
Lingler, J. H., & Klunk, W. E. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.09.014 · Cited by 44
Christensen, J., Richey, E. J., & Castañeda, H. M. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513500837 · Cited by 42
Chen, S. P., Azad, A. D., & Pershing, S. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2021.02.021 · Cited by 42
2026 Alzheimer's disease facts and figures
(2026) · Alzheimer s & Dementia · doi:10.1002/alz.71345 · Cited by 67
Declining Incident Dementia Rates Across Four Population-Based Birth Cohorts
Sullivan, K., Dodge, H. H., Hughes, T. F., Chang, C. H., Zhu, X., Liu, A., & Ganguli, M. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly236 · Cited by 40
Kesler, S. R., Acton, P., Rao, V., & Ray, W. J. (2018) · Network Neuroscience · doi:10.1162/netn_a_00048 · Cited by 34
“…age, first-degree family history, and the apolipoprotein E (APOE) e4Apolipoprotein E (APOE): A gene that encodes a protein important for the metabolism and transport of fats. genotype (Green et al., 2002; Hebert et al., 2010; Saunders et al., 1993; ten Kate et al., 2016; Wolters et al., 2017).”
BackgroundXiao, Q., Sampson, J. N., LaCroix, A. Z., Shadyab, A. H., Zeitzer, J. M., Ancoli‐Israel, S., Yaffe, K., Stone, K. L., & Osteoporotic Fractures in Men (MrOS) Study Group (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab275 · Cited by 33
Bermejo‐Pareja, F., & del Ser, T. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020536 · Cited by 39
Shastri, D., Raj, V., & Lee, S.-K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102379 · Cited by 34
Weir, D. R., Wallace, R. B., Langa, K. M., Plassman, B. L., Wilson, R. S., Bennett, D. A., Duara, R., Loewenstein, D., Ganguli, M., & Sano, M. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.11.004 · Cited by 32
Self-citationHao, L., Xing, Y., Li, X., Mu, B., Zhao, W., Wang, G., Wang, T., Jia, J., & Han, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00846 · Cited by 30
Mackenbach, J. P., Karanikolos, M., & Looman, C. W. N. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-840 · Cited by 31
Christensen, J., & Castañeda, H. M. (2014) · Journal of Gerontological Social Work · doi:10.1080/01634372.2014.898009 · Cited by 31
Novel therapeutic approaches to target neurodegeneration
de la Fuente, A. G., Pelucchi, S., Mertens, J., Luca, M. D., Mauceri, D., & Marcello, E. E. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16078 · Cited by 32
Nanoparticles-based anti-aging treatment of Alzheimer’s disease
Chu, J., Ji, W., Zhuang, J., Gong, B., Chen, X., Cheng, W., Liang, W., Li, G., Gao, J., & Yin, Y. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2094501 · Cited by 30
Zhao, J., Li, F., Wu, Q., Cheng, Y., Liang, G., Wang, X., Fang, S., Wang, Q., Fan, X., & Fang, J. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.135743 · Cited by 29
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?
Vecchio, F. L., Bisceglia, P., Imbimbo, B. P., Lozupone, M., Latino, R. R., Resta, E., Leone, M., Solfrizzi, V., Greco, A., Daniele, A., et al. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221081605 · Cited by 28
Contador, I., Buch-Vicente, B., del Ser, T., Velasco, S. L., Villarejo‐Galende, A., Benito‐León, J., & Bermejo‐Pareja, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144100 · Cited by 31
Gallego, I., Villate-Beitia, I., del Burgo, L. S., Puras, G., & Pedraz, J. L. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000418 · Cited by 26
Mwendwa, P., LAWLOR, B. A., Kroll, T., & Brún, A. D. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03668-2 · Cited by 22
Bancks, M. P., Alonso, Á., Allen, N. B., Yaffe, K. S., & Carnethon, M. R. (2019) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2018-211985 · Cited by 21
Sauty, B., & Durrleman, S. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1161527 · Cited by 24
Spatial Distribution and Secular Trends in the Epidemiology of Alzheimer's Disease
Whalley, L. J. (2012) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2011.11.002 · Cited by 19
Risk factors for dementia in highly educated elderly people in Tianjin, China
Wei, C., Cheng, Y., Zhang, Y., Sun, F., Zhang, W., & Zhang, M.-Y. (2014) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2014.04.004 · Cited by 18
Downer, B. G., García, M. A., Raji, M. A., & Markides, K. S. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy196 · Cited by 17
Aberrant DNA methylation associated with Alzheimer's disease in the superior temporal gyrus
Gao, Z., Fu, H., Zhao, L., Sun, Z., Yang, Y., & Zhu, H. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5394 · Cited by 15
Altering Mitochondrial Dysfunction as an Approach to Treating Alzheimer’s Disease
Colca, J. R., & Feinstein, D. L. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00005-2 · Cited by 14
Exploring Disasters through the Eyes of Residential Nursing Home Caregivers
Uekusa, S. (2019) · Social Work in Public Health · doi:10.1080/19371918.2019.1635942 · Cited by 14
Fuller‐Thomson, E., & Ahlin, K. M. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210561 · Cited by 12
Gollan, T. H., Smirnov, D. S., Salmon, D. P., & Galasko, D. (2020) · Psychology and Aging · doi:10.1037/pag0000550 · Cited by 13
Merde, İ. B., Önel, G. T., Türkmenoğlu, B., Gürsoy, Ş., & Dilek, E. (2022) · ChemistrySelect · doi:10.1002/slct.202202446 · Cited by 11
Ozone and Particulate Matter Exposure and Alzheimer’s Disease: A Review of Human and Animal Studies
Liu, R.-M., Chong, Z., & Chen, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200435 · Cited by 11
Kritz‐Silverstein, D. C., & Bettencourt, R. (2024) · Nutrients · doi:10.3390/nu16162765 · Cited by 10
Assessing brain and biological aging trajectories associated with Alzheimer’s disease
Liang, W. S., Goetz, L. H., & Schork, N. J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1036102 · Cited by 12
Metadata
- Authors
- Hebert, L. E., Bienias, J. L., Aggarwal, N. T., Wilson, R. S., Bennett, D. A., Shah, R. C., & Evans, D. A.
- Affiliations
- Rush University Medical Center (US)
- Corresponding author
- Hebert, L.E.
- Venue
- Neurology
- Published
- 2010-08-31
- Volume
- 75
- Issue
- 9
- Pages
- 786-791
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC2938969
- OpenAlex
- W2163324016
- Cited by
- 158
- References
- 23
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 12 · 2023: 8 · 2022: 19 · 2021: 16 · 2020: 10 · 2019: 18 · 2018: 15 · 2017: 14 · 2016: 5 · 2015: 5 · 2014: 7 · 2013: 4 · 2012: 3
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AG11101)
- National Institute on Aging (RC2AG036650, R01AG017917, P30-AG 10161, U01AG012505, R01AG030146, AG 10161, R01 AG15819, AG029652, AG030146, R01AG11101, AG09966, AG-11101, R01AG030142, R01AG032247, U01 AG016979, R01AG011101, R01AG036042, U01AG010483, R01AG015819, P30AG010161, P01AG01449, AG036650, R01AG032755, R01AG030544, RC2AG036547, AG021972, R01AG024480, R01AG021972, P01AG009466, U24AG026395, P30 AG101061, 01AG032984, AG12505, R03AG029652, R01AG009966, R01AG024871, R01AG033678, R01AG034374, R01AG022018)
- National Heart, Lung, and Blood Institute (HL 084209, R01HL084209, R01HL096944)
- National Institute of Nursing Research (R01NR009543, R01NR010211, NR009543)
- National Institute of Environmental Health Sciences (R01ES010902, ES 10902)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- Alzheimer's disease, incidence, oldest old, cognitive function
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Alzheimer Disease, Black or African American, Chicago, Female, Humans, Longitudinal Studies, Male, Risk Factors, Sex Factors, Socioeconomic Factors, Time Factors, Cohort Studies, Incidence, Black People, White People, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review